baber/WOPTO huggingface dataset:
Patent NZ-517437-A (NZ)
Title: Improvements relating to catheter positioning
Inventor: NASHEF AWS
IPC: A61B5/028
Filed: 2000-08-25
Abstract: A catheter which includes means to measure local pressure at two or more points along the catheter body is described. The points are preferably located in two different pressure areas, more preferably across a valve in a vessel, organ or similar. The invention provides a method of gauging the positional location of a catheter in a blood vessel, organ or similar, either by the catheter having means to monitor the local pressure at two or more points along the catheter body, or means to measure pressure at a single point along the catheter body, which catheter is moveable to detect pressure differential measurements. The invention can be used to more accurately have knowledge of the position of a blood vessel, by means of a heat transfer device.
Patent NZ-518816-A (NZ)
Title: Substituted homopiperidinyl benzimidazole analogues useful as fundic relaxants
Inventor: JANSSENS FRANS EDUARD
IPC: A61K31/55
Filed: 2000-12-14
Abstract: A homopiperidinyl benzimidazole derivative or a N-oxide, addition salt, quaternary amine and stereochemically isomeric form thereof has the formula (I) wherein: the ring A is a group of formula (a-1) to (a-12); R2 is hydrogen, hydroxy, alkyl, or alkyloxy, and when R2 is hydroxy or alkyloxy then R2 is bonded at a different position than the a-position of the ring nitrogen, or when R2 is hydroxy then R2 is bonded at a different position than a vinylic position of radical (a-2), (a-3), (a-4), (a-5), (a-6), (a-8), (a-9), (a-10), (a-11), or (a-12); -a1=a2-a3=a4- is a bivalent radical of formula -CH=CH-CH=CH- (b-1), -N=CH-CH=CH- (b-2), -CH=N-CH=CH- (b-3), -CH=CH-N=CH- (b-4), -CH=CH-CH=N- (b-5), -CH=CH-N=N- (b-6), -N=CH-CH=N- (b-7), -N=CH-N=CH- (b-8), -N=N-CH=CH- (b-9), -CH=N-CH=N- (b-10) or -CH=N-N=CH- (b-11) wherein each hydrogen atom in the radicals (b-1) to (b-11) may optionally be replaced by halo, alkyl, nitro, amino, hydroxy, alkyloxy, polyhaloalkyl, carboxyl, aminoalkyl, hydroxyalkyl, monoalkyl- or dialkyl-aminoalkyl or alkyloxycarbonyl or wherein two hydrogen atoms on adjacent carbon atoms in the radicals (b-1) to (b-11) may optionally be replaced by -(CH2)4-; R1 is hydrogen, alkyl, aryl1, aryl1alkyl, alkyloxycarbonyl, aryl1carbonyl, aryl1alkylcarbonyl, aryl1carbonylalkyl, aryl1oxycarbonyl, aryl1alkyloxycarbonyl, alkylcarbonyl, trifluoromethyl, trifluoromethylcarbonyl, alkylsulphonyl, aryl1sulphonyl, methanesulphonyl, benzenesulphonyl, trifluoromethanesulphonyl or dimethylsulphamoyl; X is O, S or NR3; R3 is hydrogen, alkyl, methanesulphonyl, benzenesulphonyl, trifluoromethanesulphonyl, dimethylsulphamoyl, aryl2carbonylalkyl, alkyloxycarbonyl, aryl2alkyl optionally substituted with hydroxy or aryl2alkylcarbonylalkyl; aryl1 is naphthyl, quinolinyl, 1,3-benzodioxolyl,  furanyl, thienyl or benzofuranyl or optionally substituted phenyl or pyridinyl and aryl2 is optionally substituted phenyl. The compounds are useful as a medicine for treating dyspeptic symptoms, irritable bowel syndrome and other conditions related to a hampered or impaired relaxation of the fundus.
Patent NZ-527788-A (NZ)
Title: Desk and desking system
Inventor: BROOKS STEVEN
IPC: G06F/
Filed: 2002-01-28
Abstract: A desk is adapted for connection to a second desk as part of a network of desks. The desk includes a desktop, a chassis positioned substantially beneath the desktop and including one or more cassettes, wherein at least one cassette includes one or more electronic components, a power distribution system providing power to at least one cassette and configured to provide power to at least one adjacent desk, and an electronic connection system providing an electronic connection from the one or more electronic components to an electronic component located in an adjacent second desk. The power distribution system and the electronic connection system are positioned substantially beneath the desktop and extend approximately from a first side of the desktop to a second side of the desktop.
Patent NZ-528452-A (NZ)
Title: Absorbent product for improved fit by stiffening element contributing to three-dimensional shape of product in use
Inventor: DREVIK SOLGUN
IPC: A61F5/44
Filed: 2002-04-05
Abstract: Absorbent product, such as a sanitary towel, which product has a stiffening element (6) which is intended to contribute to the three-dimensional shape of the product during its use. The stiffening element (6) is in a plane state before use of the product and extends in the longitudinal direction of the product over the crotch portion (3) and at least some way in over the front portion (1). The stiffening element (6) has a width (M) at the transition (12) between the crotch portion (3) and the front portion (1) which is adapted to the distance between the muscle tendons of the wearer on both sides of the crotch of the wearer in the groin of the latter and which is of the order of 15-45 mm. The stiffening element (6) extends some way in over the rear portion (2) and there consists of two separate portions (14, 15), one on each side of a longitudinal centre line (L).
Patent NZ-530193-A (NZ)
Title: Metal-containing compositions, preparations and uses
Inventor: HICKOK STEPHEN SPAULDING
IPC: A23L1/304
Filed: 2000-08-31
Abstract: A metal- or mineral element-containing composition which comprises: (i) one or more compounds of the following elements: zinc, magnesium, copper, selenium, iron, nickel, titanium, vanadium or aluminium being water soluble and able to form corresponding ions of the aforesaid element when dissolved in water, (ii) one or more ammonium metal ion binding, complexing or sequestering agents, (iii) one or more acids, and (iv) water, is disclosed. The composition has a pH of less than 3 and an electrolytic potential in excess of 200 millivlots. The composition may also comprise one or more additives selected from the group consisting of: vitamin B1, vitamin B3, vitamin B5, vitamin B6, vitamin C, malic acid, a natural diuretic, melatonin and valerian. A method of making the described composition is also disclosed. The composition may be form part of an antimicrobial, antiviral, antiretrovirus or antifungal formulation. The composition may be useful for: -the treatment of foodstuffs as a disinfectant or bactericide -the preservation of plants, flowers, trees or shrubs -the treatment of metal for coating, sealing, plating or otherwise forming an anti-corrosive layer upon a metallic substrate -use in treating or preventing a pathogenic disease or disorder. A mineral dietary supplement containing the described composition is also disclosed. (62) Divided out of 517330
Patent NZ-530300-A (NZ)
Title: Locking mechanism for air handler (AHU) cabinet
Inventor: HERBECK CHRISTIAN C
IPC: E04B1/61
Filed: 2002-07-11
Abstract: A locking mechanism (50) for an air handling duct (10) includes a plurality of interconnected modules which together make up the duct. The locking mechanism includes a male retainer contained on a frame member of a first module, with the male retainer having a locking arm (54) adapted to be moved from an unlocked position to a locked position. A complementary female retainer (46) is contained on a frame member of a second module, with the female retainer being in the form of an elongated keyway designed to receive and hold the locking arm in a locked position. Means (62) are provided to move the arm from an unlocked position to a locked position when the male and female retainers are in alignment for locking the modules together.
Patent NZ-530851-A (NZ)
Title: Microcell electrochemical devices and assemblies, and method of making and using the same
Inventor: ESHRAGHI RAY
IPC: H01M50/469
Filed: 2001-07-23
Abstract: Disclosed is a process for manufacturing a fibrous microcell article, comprised of the following steps (i) disposing the electrolyte material in pores of a microcell precursor article that comprises of at least one current collector within a porous membrane separator arranged in dispensing relationships (ii) drying the precursor article (iii) applying electrocatalyst material in the form of solution or ink slurry to the precursor article (iv) drying the precursor article and (v) reducing the electrocatalyst material to a catalytically active form, using an electrocatalyst reducing solution. (62) Divided out of 523874
Patent NZ-536409-A (NZ)
Title: New piperazine compounds and their use in the treatment of serotonin-related disorders
Inventor: NILSSON BJORN
IPC: A61P13/02
Filed: 2003-05-16
Abstract: Disclosed are compounds of general formula (I), pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament which particularly acts on the central nervous system, particularly for use as anti-obesity agents.
Patent NZ-540301-A (NZ)
Title: System and method for managing data using static lists
Inventor: MOORE JASON F
IPC: G06F17/21
Filed: 2004-07-27
Abstract: A computer-implemented method for managing data in a list comprises creating a list having an item type and a relationship type; adding an item to the list by generating a list entry representing an association between an item and the item type and storing the list in a memory of a data processing device. The list entry comprises one or more item properties specified by the relationship type. A system for managing data, the system comprises a storage medium for storing items of data and a list entry template; a processing unit for operating a process to generate a list of selected items in response to a user input and a display unit for displaying a view of the items in the list, the view including a display of the property values of the entry in accordance with a display characteristic. Each entry of the list represents a reference to the item independent of the item's location in the storage medium, and each entry includes a property value generated in accordance with the list entry template.
Patent NZ-541990-A (NZ)
Title: Method for preparing polymorphism of irinotecan hydrochloride
Inventor: SHIMIZU HIDEAKI
IPC: A61P35/00
Filed: 2004-02-24
Abstract: Disclosed is a method for preparing c-type crystals of irinotecan hydrochloride, including mixing irinotecan with one or more solvents selected from the group consisting of acetone, acetonitrile and tetrahydrofuran, adding hydrochloric acid, and collecting the formed crystals.
Patent NZ-542591-A (NZ)
Title: High drug load sachet containing 5-aminosalicylic acid
Inventor: JEPSEN SVENN KLUVER
IPC: A61K31/60
Filed: 2004-04-23
Abstract: Disclosed is an oral pharmaceutical formulation in the form of a granulate comprising more than 60% by weight of mesalazine or a pharmaceutically acceptable salt thereof, wherein said pharmaceutical formulation is packed in a sachet, capsule or blister package. Also disclosed is the use of mesalazine for the manufacture of the above pharmaceutical formulations comprising a total dosage amount of mesalazine chosen among the group consisting of: 0.5 g; 1.0 g; 1.5 g; 2 g; 3 g; 4g; 5 g; 6 g; 8 g, wherein the medicament is for the treatment of intestinal bowel disease.
Patent NZ-545255-A (NZ)
Title: Inhalation actuated medicament inhaler with dose counter
Inventor: I-CHE LEE JAMES
IPC: A61M15/00
Filed: 2004-07-13
Abstract: An inhaler 20 for dispensing metered doses of a medicament includes a passageway 80, 82 through which the inhalation breath of a user will flow, and a collapsible retainer 24, 66 movable between a first configuration (as shown) in which a medicament container 22 is retained in a stowed position and a second configuration in which the retainer is collapsed so that the medicament container can move to a discharge position in which medicament is dispensed into the passageway. A latch 34 releasably supports the collapsible retainer in the first configuration and is operable in response to flow of inhalation breath in the passageway to move out of engagement with the collapsible retainer to allow the retainer to collapse into the second configuration and thereby medicament to be dispensed into the breath as the patient inhales.
Patent NZ-545628-A (NZ)
Title: Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
Inventor: WILSON JAMES M
IPC: A61K48/00
Filed: 2004-09-30
Abstract: Disclosed is an isolated adeno-associated virus (AAV) of serotype 9 comprising an AAV capsid and a heterologous molecule for delivery to a cell, wherein the AAV capsid is at least about 95% identical to the amino acid sequence of SEQ ID NO: 123 over amino acids 1 to 736.
Patent NZ-548731-A (NZ)
Title: Isothermal detection methods and uses thereof
Inventor: SAUL DAVID JAMES
Filed: 2006-07-24
Abstract: A method for detecting a target nucleic acid in a sample, the method comprising the steps a) providing a sample containing a target nucleic acid sequence, b) providing a dimeric polynucleotide probe comprising a first nucleic acid molecule having a single stranded region, the single stranded region comprising a target binding domain, the target binding domain comprising a nuclease cleavage element or being susceptible to nuclease degradation, the probe comprising a second nucleic acid molecule hybridisable to the first nucleic acid molecule, the second nucleic acid molecule comprising at least one copy of the target nucleic acid sequence, or a detection sequence, or both, and wherein the probe comprises a detectable label, or the detection sequence, or both a detectable label and the detection sequence, c) contacting the sample with more than one copy of the probe, wherein the target binding domain binds the target nucleic acid sequence, d) contacting the sample with a first nuclease to cleave the nuclease cleavage element or degrade the target binding domain, e) separating the first and second nucleic acid molecules of the dimeric probe to expose the at least one copy of the target nucleic acid sequence on the second nucleic acid molecule, or the detection sequence, or both, wherein this separation allows the target binding domain of the probe to bind the exposed at least one copy of the target nucleic acid sequence on the second nucleic acid molecule, and the exposure of additional copies of the at least one copy of the target nucleic acid sequence, or the detection sequence, or both, f) detecting the target nucleic acid sequence, or the detection sequence, or both, by detecting or measuring the signal of the detectable label, or by contacting the sample with a second probe that binds the detection sequence, the second probe carrying a detectable label, and detecting or measuring the signal of the detectable label, wherein an increase in signal is indicative of the presence of the target nucleic acid in the sample. Also disclosed is a probe used in said method.
Patent NZ-551426-A (NZ)
Title: Floor cleaning machine
Inventor: MAYER HEINRICH-TITO
IPC: A47L11/28
Filed: 2005-05-03
Abstract: An electric drive, ride on floor cleaning machine 1 has at least one front wheel 5 and two rear wheels 6a. The machine has one or two drive wheels with each drive wheel having an electric mono wheel drive. The operator 8 stands on a platform 9 that is located over the central axis of the machine between the two rear wheels 6a, and that has a maximum height above the floor of 200 mm.
Patent NZ-551638-A (NZ)
Title: Microbial glyphosate resistant 5-enolpyruvylshikimate-3-phosphate synthases
Inventor: ALIBHAI MURTAZA F
IPC: C12N9/10
Filed: 2005-06-20
Abstract: Provided is a chimeric DNA construct comprising a promoter molecule functional in a plant cell operably linked to an artificial polynucleotide molecule encoding a Caulobacter glyphosate resistant 5-enolpyruvyl-3-phosphoshikimate synthase (EPSPS) polypeptide, wherein said EPSPS polypeptide comprises the sequence domains G-D-K-S; S-A-Q-X2_K, in which X2 is I or V; and R-D-H-T-E, and N-E-L-R. Further provided are transgenic plants and seed comprising the DNA construct and a method of selectively killing weeds with glyphosate in a field planted with such transgenic plants.
Patent NZ-556115-A (NZ)
Title: A sequential treatment apparatus and process
Inventor: HAWES COLIN TERRENCE
IPC: C02F9/00
Filed: 2007-06-22
Abstract: A method of treating a raw substance using a treatment apparatus including a plurality of treatment units, a housing, a connection assembly, a partition system, that is movable between a primary configuration and a secondary configuration, including the steps of: (a) moving the partition system into the first configuration to define a first fluid flow arrangement, (b) directing the raw substance through the plurality of treatment units; (c) moving the partition system into the secondary configuration to define a second fluid flow arrangement and stop the raw substance moving through the plurality of treatment units; and (d) directing a cleaning substance through the plurality of treatment units. An apparatus for performing the method is also disclosed.
Patent NZ-565067-A (NZ)
Title: A mug holder that surrounds lower part of a mug and its handle and can nest with others for transport
Inventor: MATTHEWS ALLY JOE
IPC: A47G19/06
Filed: 2008-01-11
Abstract: A support (1) for stabilising a handled mug (8) on a table or the like is disclosed. The support (1) effectively widens the base area of the mug (8) helping to prevent any spills. The support (1) has a body (2) with a shaped cavity (5) having tapered sides. The cavity (5) has two parts the first being configured to receive the main body of the handled container the second part configured to surround a portion of the mug's handle (9). The tapered sides mean that two or more of the supports may nest within each other for compact transportation. The support (1) may of course be used for any other type of container for beverages, with or without a handle and afford a similar protection from spills.
Patent NZ-573923-A (NZ)
Title: Wind system for converting energy through a vertical-axis turbine actuated by means of kites and process for producing electric energy through such system
Inventor: IPPOLITO MASSIMO
IPC: F03D3/06
Filed: 2007-06-13
Abstract: Disclosed is a system for converting wind energy. The system comprises at least one kite (1) that can be driven from ground immersed in at least one wind current W, and a vertical-axis wind turbine (2) placed at ground level. The wind turbine is equipped with at least one arm (3) connected through two ropes (4) to the kite. The kite is adapted to be driven through the turbine to rotate the arm and convert wind energy into electric energy, through at least one generator/motor system operating as generator that co-operates with the turbine. The ropes are adapted both to transmit mechanical energy from and to the kites, and to control a flight trajectory of the kites. The system further comprises a smart control system which automatically controls the kites along the flight trajectory. The smart control system is equipped with a set of sensors placed on the kites and a set of ground sensors.
Patent NZ-585510-A (NZ)
Title: Cushion for respiratory mask assembly with face contacting portion having pre-formed notch for nose
Inventor: FU TIMOTHY TSUN-FAI
IPC: A61M16/08
Filed: 2003-09-05
Abstract: A cushion for a respiratory mask assembly has a non-face contacting portion 24 connected to a frame, a face-contacting portion 26 structured to engage the patient's face, and an intermediate portion 28 that interconnects the portions 24, 26 which has a gusset portion to apply a component of force to the patient's face through portion 26. Portion 28 is curved as viewed from above to follow the contour of the patient's face. Portion 26 has a membrane with a preformed contoured notch 48 in a nasal bridge region to match contours of the patient's nasal bridge. The drawing shows a cushion in sectional upward view.
Patent NZ-586148-A (NZ)
Title: Remedies for pemphigus containing anti fas ligand antibodies
Inventor: PINCELLI CARLO
IPC: A61K39/395
Filed: 2008-12-12
Abstract: Use of a monoclonal antibody or an antigen-binding fragment thereof specific for human Fas ligand protein (FasL), wherein said monoclonal antibody comprises at least one heavy chain variable region and at least one light chain variable region, wherein the amino acid sequences of the complementary determining region (CDRs) of the heavy chain are: (a1) CDR H1: EYPMH or a sequence that has at least 70% sequence identity; (b1) CDR H2: MIYTDTGPSYAEEFKG or a sequence that has at least 70% sequence identity; (c1) CDR H3: FYWDYFDY or a sequence that has at least 70% sequence; and the amino acid sequences of the complementary determining regions (CDRs) of the light chain are: (a2) CDR L1: RASQDISNYLN or a sequence that has at least 70% sequence identity; (b2) CDR L2: YTSRLHS or a sequence that has at least 70% sequence identity; (c2) CDR L3: QQGSTLPWT or a sequence that has at least 70% sequence identity; for the manufacture of a medicament for the prevention and/or treatment of a skin disease associated with keratinocyte acantholysis Further disclosed is the use of the monoclonal antibody produced by the hybridoma cell under Accession No. BP-5535 or an antibody or a functional antibody fragment derived therefrom, for the manufacture of a medicament for the prevention and/or treatment of a skin disease associated with keratinocyte acantholysis.
Patent NZ-586225-A (NZ)
Title: Kappa selective opioid receptor antagonist
Inventor: DIAZ BUEZO NURIA
IPC: A61P25/32
Filed: 2009-01-13
Abstract: 3-Fluoro-4-[4-[2-(3,5-dimethylphenyl)pyrrolidin-1-ylmethyl]phenoxy]benzamide of structural formula depicted herein and a pharmaceutically acceptable salt thereof is disclosed. This compound is suitable for use in the treatment of: (a) an anxiety disorder selected from panic disorder, obsessive-compulsive disorder, social phobia, generalized anxiety disorder, specific phobia, and posttraumatic stress disorder; or (b) a depressive illness selected from major depression, dysthymia and bipolar disorder; or (c) an anxiety disorder selected from (a) and a depressive illness selected from b); or (d) ethanol use disorder and an anxiety disorder selected from a); or (e) ethanol use disorder and a depressive illness selected from (b); or (f) ethanol use disorder and an anxiety disorder selected from (a) and a depressive illness selected from (b); or (g) schizophrenia; or (h) ethanol use disorder and schizophrenia
Patent NZ-587133-A (NZ)
Title: Macrocyclic serine protease inhibitor compounds for treating an HCV infection
Inventor: PARSY CHRISTOPHE CLAUDE
IPC: A61K31/407
Filed: 2009-02-03
Abstract: Disclosed herein are macrocyclic serine protease inhibitor compounds of formula (I), pharmaceutical compositions comprising the compounds, and processes of preparation thereof, wherein the variables are as defined in the specification. These macrocyclic serine protease inhibitor compounds are suitable for treating or preventing an HCV infection. Also disclosed are medicament combinations comprising said macrocyclic serine protease inhibitor compound in combination with a second antiviral agent selected from the group consisting of an interferon, ribavirin, amantadine, an interleukin, a NS3 protease inhibitor, a cysteine protease inhibitor, a phenathrenequinone, a thiazolidine, a benzanilide, a helicase inhibitor, a polymerase inhibitor, a nucleotide analogue, a liotoxin, acerulenin, an antisense phosphorothioate oligodeoxynucleotide, an inhibitor of IRES-dependent translation, and a ribozyme.